Save the Date - October 1-4, 2020 - IWWM-11 Madrid, Spain
The 11th International Workshop for Waldenstrom's Macroglobulinemia is being held October 1-4, 2020 in Madrid, Spain. The venue chosen for this meeting is one of Madrid’s premier hotels, Westin Palace Madrid, situated in the Las Letras quarter. The hotel nestles in one of the city’s most historic areas linking the city’s most enriching museums, Prado, Reina Sofia and Thyssen-Bornemisza, vibrant parks and gardens, and epicurean eateries. Onsite registration and check-in begin at 14:00 (2:00pm) on Wednesday, September 30th, conference sessions starting on Thursday, October 1, at 8:00am.
The Workshop’s mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic system, by promoting targeted research, clinical care methods, education, training, and advocacy for Waldenstrom’s macroglobulinemia. IWWM-11 will continue to support future research by including a Junior Investigator Poster presentation event with short oral presentations. Abstract submissions for poster presentations will begin in June 2020.
Read more: Save the Date - October 1-4, 2020 - IWWM-11 Madrid, Spain
Waldenstrom's Macroglobulinemia Clinic
The Waldenstrom's Macroglobulinemia Clinic at the DFCI is devoted to the care of patients with Waldenstrom's Macroglobulinemia and related IgM disorders, including IgM MGUS, Myeloma and Neuropathies.
For more information on the WM Clinic at DFCI, please visit the DFCI Center for Hematologic-Oncology/Waldenstrom's Macroglobulinemia Clinic.
Basic Research
Waldenström’s macroglobulinemia (WM) is a distinct B-cell malignancythat results from the accumulation, predominantly in the bone marrow, of clonally related B type lymphocytes, lymphoplasmacytic cells and plasma cells which secrete a monoclonal IgM protein.1 This condition is considered to correspond to the lymphoplasmacytic lymphoma (LPL) as defined by the World Health Organization classification system.2 Most cases of LPL are WM, with less than 5% of cases made up of IgA, IgG and non-secreting LPL ...
Latest Bing Center News
Latest News in the Treatment of WM - TELECONFERENCE 3/19/2020
CancerCare, in association with the IWMF, is holding a Teleconference titled – The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia on Thursday, March 19th from 1:10-2:30 pm Eastern Time (ET). Presenting will be Steven Treon, MD, Ph.D, Christian Buske, MD, Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW, and Carl Harrington (IWMF).
25th Annual IWMF Educational Forum
25th Annual IWMF Educational ForumJune 5-7, 2020Renton, WA"2020 Vision: A World Without WM"
Steven Treon, MD, PhD to serve as advisor to IWMF Board
Dr. Steven Treon, MD, PhD, (Dana-Farber Cancer Institute) has agreed to advise the IWMF Board of Trustees. Dr. Treon joins Dr. Ansell of the Mayo Clinic in providing the critical perspective of world-renowned clinicians/researchers to the IWMF Board. Dr. Treon and Dr. Ansell also will jointly co-chair the IWMF Scientific Advisory Committee.
Florida Blood Cancer Conference 2020 (LLS)
Dr. Steven Treon will be lecturing at the upcoming Blood Cancer Conference (BCC), one of many programs developed by The Leukemia & Lymphoma Society (LLS) to meet the needs of patients, survivors, families and oncology professionals, the people who deal with blood cancer every day and the people who care for them. BCC attendees receive the most current information and access to local resources to help navigate and make informed decisions about their treatment and survivorship.
ASH 2019 - Bing Center Presentations
The ASH 2019 conference was held in Orlando, FL from December 7-10, 2019. Researchers from the Bing Center contributed an oral presentation (Guang Yang), and three posters (Jorge Castill, and Xia Liu).
IWMF Adds Three Members to Scientific Advisory Committee
The IWMF is proud to welcome three new members to its Scientific Advisory Committee (SAC) chaired by Dr. Stephen Ansell of the Mayo Clinic and Dr. Steven Treon of the Dana-Farber Cancer Institute. The new members, Dr. Zachary Hunter from Dana-Farber, Boston, USA, Dr. Christian Buske from Ulm, Germany, and Dr. Monique Minnema of The Netherlands, were invited to participate because of their expertise in specific research areas identified by the IWMF-LLS Strategic Research Roadmap for WM.
Dr. Edward Laane - Running for WM! (Part-2)
On November3, 2019, Dr. Edward Laane ran the Osaka Yodo River Half Marathon, to raise money for Waldenstrom's research. His pure running time was 2.26.07 with his official time listed at 2.31.0. As Dr. Laane recalls, "The run was difficult. It was sunny, and a little bit hot. The first part, 6.5 miles was a little easier. My time was approximately 1h 10 min, but the second part was very difficult. But I was thinking about the patients who have gone through so much treatment and this gave me more strength to finish.
New Approaches to treating Waldenstrom's Macroglobulinemia
At the 2019 Lymphoma & Myeloma Congress, Steven Treon, MD, PhD, FACP, FRCP, Harvard University, Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, Massachusetts, provided an update on the latest research in the treatment of Waldenström Macroglobulinemia.
Dr. Edward Laane - Running for WM!
Dr. Edward Laane is running in the Osaka Yodo River Citizens Marathon to raise money for Waldenstrom's research!
IMW-17 Young Investigator Awards
Congratulations to the following Bing Center researchers for their Young Investigator Awards at the 17th International Workshop on Multiple Myeloma!